大博医疗：9月17日召开董事会会议

Group 1 - The core point of the article is that Dabo Medical (SZ 002901) announced the convening of its 19th meeting of the third board of directors on September 17, 2025, to review the proposal for adjusting the exercise price of the 2024 stock option incentive plan [1] - For the first half of 2025, Dabo Medical's revenue composition is entirely from the medical device manufacturing industry, accounting for 100.0% [1] - As of the time of reporting, Dabo Medical has a market capitalization of 22.6 billion yuan [1]